과민성폐렴의 진단, 임상 경과 및 치료

키워드

참고문헌 (41)

1. Raghu G, "Diagnosis of hypersensitivity pneumonitis in adults. An official ATS", JRS, Am J Respir Crit Care Med, pp.2020, 202[DOI]
2. Pérez ERF, "Diagnosis and evaluation of hypersensitivity pneumonitis : CHEST guideline and expert panel report", Chest, 160, pp.e97~e156 (2021)
3. "Interstitial lung disease (ILD) clinical practice guidelines (2023 1st revised)" (2023)[URL]
4. Girard M, "Impaired function of regulatory T-cells in hypersensitivity pneumonitis", Eur Respir J, 37, pp.632~639 (2011)
5. Vasakova M, "Hypersensitivity pneumonitis : current concepts of pathogenesis and potential targets for treatment", Am J Respir Crit Care Med, 200, pp.301~308 (2019)
6. Camarena A, "Major histocompatibility complex and tumor necrosis factor-alpha polymorphisms in pigeon breeder's disease", Am J Respir Crit Care Med, 163, pp.1528~1533 (2001)
7. Ley B, "The MUC5B promoter polymorphism and telomere length in patients with chronic hypersensitivity pneumonitis : an observational cohort-control study", Lancet Respir Med, 5, pp.639~647 (2017)
8. Newton CA, "Telomere-related lung fibrosis is diagnostically heterogeneous but uniformly progressive", Eur Respir J, 48, pp.1710~1720 (2016)
9. Ley B, "Rare protein-altering telomere-related gene variants in patients with chronic hypersensitivity pneumonitis", Am J Respir Crit Care Med, 200, pp.1154~1163 (2019)
10. Leone PM, "Current diagnosis and management of hypersensitivity pneumonitis", Tuberc Respir Dis(Seoul), 83, pp.122~131 (2020)
11. Hamblin M, "Diagnosis, course and management of hypersensitivity pneumonitis", Eur Respir Rev, 31, pp.210169~ (2022)
12. Park MS, "Diagnosis and treatment of hypersensitivity pneumonitis", J Korean Med Assoc, 52, pp.49~58 (2009)
13. Kang J, "Acute exacerbation of fibrotic hypersensitivity pneumonitis : incidence and outcomes", Respir Res, 22, pp.152~ (2021)
14. Johannson KA, "Exposure assessment tools for hypersensitivity pneumonitis. An official American Thoracic Society workshop report", Ann Am Thorac Soc, 17, pp.1501~1509 (2020)
15. Meyer KC, "An official American Thoracic Society clinical practice guideline : the clinical utility of bronchoalveolar lavage cellular analysis in interstitial lung disease", Am J Respir Crit Care Med, 185, pp.1004~1014 (2012)
16. Soumagne T, "Current and emerging techniques for the diagnosis of hypersensitivity pneumonitis", Expert Rev Respir Med, 12, pp.493~507 (2018)
17. Iftikhar IH, "Transbronchial lung cryobiopsy and video-assisted thoracoscopic lung biopsy in the diagnosis of diffuse parenchymal lung disease. A meta-analysis of diagnostic test accuracy", Ann Am Thorac Soc, 14, pp.1197~1211 (2017)
18. Lynch DA, "CT phenotypes in hypersensitivity pneumonitis", Chest, 155, pp.655~656 (2019)
19. Barnett J, "Variable utility of mosaic attenuation to distinguish fibrotic hypersensitivity pneumonitis from idiopathic pulmonary fibrosis", Eur Respir J, 54, pp.1900531~ (2019)
20. Chami HA, "Transbronchial biopsy and cryobiopsy in the diagnosis of hypersensitivity pneumonitis among patients with interstitial lung disease", Ann Am Thorac Soc, 18, pp.148~161 (2021)
21. Alberti ML, "Comparative survival analysis between idiopathic pulmonary fibrosis and chronic hypersensitivity pneumonitis", Pulmonology, 26, pp.3~9 (2020)
22. Choe J, "Serial changes of CT findings in patients with chronic hypersensitivity pneumonitis : imaging trajectories and predictors of fibrotic progression and acute exacerbation", Eur Radiol, 31, pp.3993~4003 (2021)
23. Salisbury ML, "Hypersensitivity pneumonitis : radiologic phenotypes are associated with distinct survival time and pulmonary function trajectory", Chest, 155, pp.699~711 (2019)
24. Lima MS, "Subacute and chronic hypersensitivity pneumonitis : histopathological patterns and survival", Respir Med, 103, pp.508~515 (2009)
25. De Sadeleer LJ, "Impact of BAL lymphocytosis and presence of honeycombing on corticosteroid treatment effect in fibrotic hypersensitivity pneumonitis : a retrospective cohort study", Eur Respir J, 55, pp.1901983~ (2020)
26. Jacob J, "Automated computer-based CT stratification as a predictor of outcome in hypersensitivity pneumonitis", Eur Radiol, 27, pp.3635~3646 (2017)
27. Gimenez A, "Change in FVC and survival in chronic fibrotic hypersensitivity pneumonitis", Thorax, 73, pp.391~392 (2018)
28. Salisbury ML, "Diagnosis and treatment of fibrotic hypersensitivity pneumonia. Where we stand and where we need to go", Am J Respir Crit Care Med, 196, pp.690~699 (2017)
29. Adegunsoye A, "Outcomes of immunosuppressive therapy in chronic hypersensitivity pneumonitis", ERJ Open Res, 3, pp.00016-2017~ (2017)
30. Morisset J, "Use of mycophenolate mofetil or azathioprine for the management of chronic hypersensitivity pneumonitis", Chest, 151, pp.619~625 (2017)
31. Ferreira M, "Efficacy and safety of rituximab in patients with chronic hypersensitivity pneumonitis(cHP) : a retrospective, multicentric, observational study", Respir Med, 172, pp.106146~ (2020)
32. Flaherty KR, "Nintedanib in progressive fibrosing interstitial lung diseases", N Engl J Med, 381, pp.1718~1727 (2019)
33. Wells AU, "Nintedanib in patients with progressive fibrosing interstitial lung diseases-subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial : a randomised, double-blind, placebo-controlled, parallel-group trial", Lancet Respir Med, 8, pp.453~460 (2020)
34. Behr J, "Pirfenidone in patients with progressive fibrotic interstitial lung diseases other than idiopathic pulmonary fibrosis(RELIEF) : a double-blind, randomised, placebo-controlled, phase 2b trial", Lancet Respir Med, 9, pp.476~486 (2021)
35. Pérez ERF, "Pirfenidone in fibrotic hypersensitivity pneumonitis : a double-blind, randomised clinical trial of efficacy and safety", Thorax, 78, pp.1097~1104 (2023)
36. "Fibrosing ILD" (2024)[URL]
37. Jacobs SS, "Home oxygen therapy for adults with chronic lung disease. An official American Thoracic Society clinical practice guideline", Am J Respir Crit Care Med, 202, pp.e121~e141 (2020)
38. Holland AE, "Principles of rehabilitation and reactivation : interstitial lung disease, sarcoidosis and rheumatoid disease with respiratory involvement", Respiration, 89, pp.89~99 (2015)
39. Wijsenbeek MS, "Comprehensive supportive care for patients with fibrosing interstitial lung disease", Am J Respir Crit Care Med, 200, pp.152~159 (2019)
40. Kern RM, "Lung transplantation for hypersensitivity pneumonitis", Chest, 147, pp.1558~1565 (2015)
41. Tomioka H, "Japanese clinical practice guide 2022 for hypersensitivity pneumonitis", Respir Investig, 62, pp.16~43 (2024)

관련 논문AI추천